215 related articles for article (PubMed ID: 25887043)
21. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
22. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
[TBL] [Abstract][Full Text] [Related]
24. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.
Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O
Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506
[TBL] [Abstract][Full Text] [Related]
25. Development of single nanometer-sized ultrafine oxygen bubbles to overcome the hypoxia-induced resistance to radiation therapy via the suppression of hypoxia-inducible factor‑1α.
Iijima M; Gombodorj N; Tachibana Y; Tachibana K; Yokobori T; Honma K; Nakano T; Asao T; Kuwahara R; Aoyama K; Yasuda H; Kelly M; Kuwano H; Yamanouchi D
Int J Oncol; 2018 Mar; 52(3):679-686. PubMed ID: 29393397
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of AMPKα decreases ATM expression and increases radiosensitivity under hypoxia and nutrient starvation in an SV40-transformed human fibroblast cell line, LM217.
Murata Y; Hashimoto T; Urushihara Y; Shiga S; Takeda K; Jingu K; Hosoi Y
Biochem Biophys Res Commun; 2018 Jan; 495(4):2566-2572. PubMed ID: 29284117
[TBL] [Abstract][Full Text] [Related]
27. Suppression of HIF-1α expression and radiation resistance in acute hypoxic conditions.
Oike T; Suzuki Y; Al-Jahdari W; Mobaraki A; Saitoh JI; Torikai K; Shirai K; Nakano T
Exp Ther Med; 2012 Jan; 3(1):141-145. PubMed ID: 22969859
[TBL] [Abstract][Full Text] [Related]
28. Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.
Pencreach E; Guérin E; Nicolet C; Lelong-Rebel I; Voegeli AC; Oudet P; Larsen AK; Gaub MP; Guenot D
Clin Cancer Res; 2009 Feb; 15(4):1297-307. PubMed ID: 19190131
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
30. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro.
Arvold ND; Guha N; Wang D; Matli M; Deen DF; Warren RS; Haas-Kogan DA
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):207-12. PubMed ID: 15850923
[TBL] [Abstract][Full Text] [Related]
32. [Effects of hypoxia on expression of HIF-1alpha,P53, and cyclin D1 in human lung adenocarcinoma cell line A549].
Yuan XL; Yu SY; Xia S; Hu JL; Hu GQ; Xu SP
Ai Zheng; 2004 Sep; 23(9):1031-5. PubMed ID: 15363196
[TBL] [Abstract][Full Text] [Related]
33. Using YC-1 to overcome the radioresistance of hypoxic cancer cells.
Moon SY; Chang HW; Roh JL; Kim GC; Choi SH; Lee SW; Cho KJ; Nam SY; Kim SY
Oral Oncol; 2009 Oct; 45(10):915-9. PubMed ID: 19457706
[TBL] [Abstract][Full Text] [Related]
34. Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions.
Potiron VA; Abderrahmani R; Giang E; Chiavassa S; Di Tomaso E; Maira SM; Paris F; Supiot S
Radiother Oncol; 2013 Jan; 106(1):138-46. PubMed ID: 23321494
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
36. Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1α.
Schilling D; Bayer C; Li W; Molls M; Vaupel P; Multhoff G
PLoS One; 2012; 7(2):e31110. PubMed ID: 22347438
[TBL] [Abstract][Full Text] [Related]
37. Activation of PI3K/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells.
Zhang Z; Yu D; Yin D; Wang Z
Anim Reprod Sci; 2011 May; 125(1-4):42-8. PubMed ID: 21477953
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
[TBL] [Abstract][Full Text] [Related]
39. PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer.
Miyasaka A; Oda K; Ikeda Y; Sone K; Fukuda T; Inaba K; Makii C; Enomoto A; Hosoya N; Tanikawa M; Uehara Y; Arimoto T; Kuramoto H; Wada-Hiraike O; Miyagawa K; Yano T; Kawana K; Osuga Y; Fujii T
Gynecol Oncol; 2015 Jul; 138(1):174-80. PubMed ID: 25913131
[TBL] [Abstract][Full Text] [Related]
40. Temsirolimus, the mTOR inhibitor, induces autophagy in adenoid cystic carcinoma: in vitro and in vivo.
Liu W; Huang S; Chen Z; Wang H; Wu H; Zhang D
Pathol Res Pract; 2014 Nov; 210(11):764-9. PubMed ID: 24767255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]